$54.680
-1.334 (-2.44%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BMRN Prediction & Forecast by Similar Chart Analysis
Alphio's BMRN stock price prediction model matches the current BioMarin Pharmaceutical Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $55.90 (+2.24%). The 1-week path is $57.80 (+5.71%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy BioMarin Pharmaceutical Inc. Stock?
Given the current price of $54.68 and the forward P/E ratio of 9.40, BioMarin Pharmaceutical Inc appears to be undervalued compared to its earnings potential. However, the RSI of 33.66 suggests that the stock is oversold, indicating a potential rebound. The main risk is the recent decline in net income, which fell to $44.76 million in Q2 2026 from $105.53 million in Q1 2026, highlighting volatility in earnings. Therefore, while there are positive catalysts such as successful clinical trials, the stock should be monitored closely before making a buy decision.
BMRN stock price ended at $54.68 on Friday, after losing -2.44%
BioMarin Pharmaceutical Inc. (BMRN) last closed at $54.68, losing -2.44%. These facts feed the 1-day and 1-week BMRN price prediction above.
Analyst Consensus
BioMarin Pharmaceutical Inc. (BMRN): 19 buy, 5 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
BioMarin Pharmaceutical Inc. (BMRN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BMRN, ranked by similarity.
Seasonality analysis for BMRN
Historically the probability of a positive October return for BMRN is 0.00%. March offers the highest probability of a positive month at 44.44%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BMRN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $56.29 | $58.23 | $68.61 | +6.49% |
| Nov 2026 | $71.73 | $79.24 | $84.14 | +44.92% |
| Dec 2026 | $59.93 | $67.88 | $73.71 | +24.14% |
In 2026, BioMarin Pharmaceutical Inc. (BMRN) is projected to range from $56.29 to $84.14.
BioMarin Pharmaceutical Inc. 2026 monthly forecast
In Oct 2026, BioMarin Pharmaceutical Inc. is projected to average $58.23, with a low of $56.29 and high of $68.61.
In Nov 2026, BioMarin Pharmaceutical Inc. is projected to average $79.24, with a low of $71.73 and high of $84.14.
In Dec 2026, BioMarin Pharmaceutical Inc. is projected to average $67.88, with a low of $59.93 and high of $73.71.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.